TRPV4 and abdominal aortic aneurysm: For example, GSK2193874 is a TRPV4 blocker with an oral activity which inhibits the formation of the abdominal aortic aneurysm by reducing the activation of smooth muscle cells and the migration of neutrophils across cells (Shannon et al., 2020).